Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion.
about
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cellsInterleukin-8 in breast cancer progression.Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studiesInterleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.Harnessing the immune system for the treatment of breast cancer.EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers.The Damaging Effect of Passenger Mutations on Cancer Progression.RefSOFI for Mapping Nanoscale Organization of Protein-Protein Interactions in Living Cells.HER2-mTOR signaling-driven breast cancer cells require ER-associated degradation to survive.RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.The HER3 pathway as a potential target for inhibition in patients with biliary tract cancersIL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma
P2860
Q28534624-053B3EA0-C33F-4E33-8E74-21CFB7D5022CQ34346108-D1294FEA-B2B2-423F-BF1D-9AD851E4444AQ35955429-4CD843E7-8450-4C83-B0AF-032042A58993Q36065268-BD07F7CC-34E3-4F97-97F4-AFF0ACB10B28Q36355925-E96D5E0A-65D7-4889-8509-9F606F6DCDA7Q36904280-AD526C20-B066-4824-8444-B2E476A701E0Q37476039-B656042C-5975-49C6-836A-E2EBF2D972CBQ37650603-1CD5BE97-7A47-4D28-A24A-F86C5F1D0BF7Q37690257-C16B868D-9095-4096-AC4B-7CADCD54B10DQ38695293-AC225DF1-D884-4D7C-9486-4FFFF619DDA0Q38768283-9A1E8F21-0814-4711-8339-571014BD6AA5Q38805265-42B8C512-A6E4-4CDC-8767-572EE58A702AQ38870753-CAD18B2D-98BD-43D1-AC98-B80142B335BDQ42505152-6C7BBB34-3379-4235-BB4A-609195EDA678Q58601441-237A5451-0EC2-4770-9B46-7BC09BD83DACQ58796360-39914537-2324-4CBC-ADCC-B46B5D67C229
P2860
Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Co-expression of HER2 and HER3 ...... rleukin-8 autocrine secretion.
@ast
Co-expression of HER2 and HER3 ...... rleukin-8 autocrine secretion.
@en
type
label
Co-expression of HER2 and HER3 ...... rleukin-8 autocrine secretion.
@ast
Co-expression of HER2 and HER3 ...... rleukin-8 autocrine secretion.
@en
prefLabel
Co-expression of HER2 and HER3 ...... rleukin-8 autocrine secretion.
@ast
Co-expression of HER2 and HER3 ...... rleukin-8 autocrine secretion.
@en
P2093
P2860
P356
P1476
Co-expression of HER2 and HER3 ...... rleukin-8 autocrine secretion.
@en
P2093
Dominique S Meyer
Gwen MacDonald
Mohamed Bentires-Alj
Nancy E Hynes
Tim-C Roloff
P2860
P2888
P356
10.1186/BCR3329
P577
2012-10-12T00:00:00Z
P5875
P6179
1016163158